Loading…

Effects of titanocene dichloride derivatives on prostate cancer cells, specifically DNA damage-induced apoptosis

BACKGROUND While locally advanced prostate cancer is initially treatable with androgen ablation, eventually cells develop a castrate‐resistant phenotype. Currently, there are no effective treatments for this form of the disease with Docetaxel only providing a small survival advantage. In this study,...

Full description

Saved in:
Bibliographic Details
Published in:The Prostate 2011-02, Vol.71 (2), p.111-124
Main Authors: Cuffe, Sandra, Dowling, Catherine M., Claffey, James, Pampillón, Clara, Hogan, Megan, Fitzpatrick, John M., Carty, Michael P., Tacke, Matthias, Watson, R. William G.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:BACKGROUND While locally advanced prostate cancer is initially treatable with androgen ablation, eventually cells develop a castrate‐resistant phenotype. Currently, there are no effective treatments for this form of the disease with Docetaxel only providing a small survival advantage. In this study, the effects of novel derivatives of titanocene dichloride on prostate cancer cell lines has been investigated. METHODS Cellular effects were assessed using the crystal violet assay and the clonogenic survival assay. Cell cycle and apoptosis were assessed by propidium iodide staining. DNA damage was analyzed by comet assay and Western analysis. DNA damage response inhibition was achieved by pre‐incubation with an ATM/ATR inhibitor; CGK733 and DNA‐PK inhibitor; DMNB. RESULTS These analogs caused a reduction in cell number. In particular titanocene Y and C had significant effects in all cell lines. A reduction in clonogenic survival was found in response to titanocene Y in three cell lines while the PC‐3 cells exhibited increased resistance.Further analysis showed no effect on cell cycle however, the analogs were found to induce apoptosis in a dose‐dependent manner in all cell lines. These analogs associate with DNA, induce DNA damage and a differential damage response. Inhibition of key regulators of this DNA damage response sensitized the PC‐3 cell line to titanocene‐induced apoptosis and significantly reduced the clonogenic capacity of the cells. CONCLUSION These results demonstrate the mechanism of action of these novel titanocene dichloride analogs and their potential use in castrate‐independent advanced prostate cancer. Prostate 71: 111–124, 2011. © 2010 Wiley‐Liss, Inc.
ISSN:0270-4137
1097-0045
DOI:10.1002/pros.21227